Dr. Shoemaker and Autism WAS Re: VIP

[Guest guest]

Thank you, Limin.

I have a lot of trouble reading so I hadn't purchased Surviving Mold, but i

just ordered it now and will give it a try.

ART testing is showing i've dramatically reduced my infection load but i'm

still quite sick. It seems I have this persistent cytokine storm going on that

Dr. Shoemaker talks about and want to try his protocol. The reason I asked

about whether anyone's tried it for autism is I have mild autism as a result of

my chronic lyme. The thing that worries me is that Shoe says in reference to

mold illness that the patient must be removed from the mold toxic environment if

the protocol is to work, and if they have a re-exposure the protocol must be

started over again. Since I still do have some lyme infection present it seems

like the biotoxins in my body can be compared to a mold patient still being in a

mold toxic environment, and every herx reaction I suffer will be like another

biotoxin exposure. So I have some doubts about whether Shoe's protocol can work

for someone with lyme. But I still have a lot to understand about this and

welcome any thoughts or information from you and others.

Thank you,

Thane

> >>

> >> Vasoactive intestinal peptide (VIP) is a peptide hormone containing 28

amino acid residues and is produced in many areas of the human body including

the gut, pancreas, and suprachiasmatic nuclei of the hypothalamus in the brain.

VIP acts as hormones, neurotransmitters, immune modulators and neurotrophes in

the body. Dr. RS recently started recommending low dose of VIP in the form of

nasal spray for treating systemic inflammation response syndrome. In the gut,

VIP stimulates pancreatic bicarbonates secretion. In the brain, VIP plays a key

role in communication between individual brain cells.

> >>

> >> Immunomodulation of innate immune responses by vasoactive intestinal

peptide (VIP): its therapeutic potential in inflammatory disease:

> >> http://www.ncbi.nlm.nih.gov/pubmed/19604262

> >>

> >> The significance of vasoactive intestinal peptide in immunomodulation:

> >> http://pharmrev.aspetjournals.org/content/56/2/249.short

> >>

> >> Is chronic fatigue syndrome an autoimmune disorder o endogenous

neuropeptides, exogenous infection and molecular mimicry?

> >> http://cfids-cab.org/cfs-inform/MitochondrialATP/staines04.pdf

> >>

> >> Limin

> >>

> >

> >

> >

> >

> > ------------------------------------

> >

> >